These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24391803)

  • 1. Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study.
    Cescon A; Patterson S; Chan K; Palmer AK; Margolese S; Burchell AN; Cooper C; Klein MB; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Raboud JM; Loutfy MR;
    PLoS One; 2013; 8(12):e83649. PubMed ID: 24391803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
    Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
    AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy.
    Raboud J; Blitz S; Walmsley S; Thompson C; Rourke SB; Loutfy MR;
    HIV Clin Trials; 2010; 11(6):340-50. PubMed ID: 21239362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.
    Milloy MJ; Kerr T; Buxton J; Rhodes T; Krusi A; Guillemi S; Hogg R; Montaner J; Wood E
    J Acquir Immune Defic Syndr; 2012 Apr; 59(4):393-9. PubMed ID: 22134149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
    Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
    AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada.
    Benoit AC; Younger J; Beaver K; Jackson R; Loutfy M; Masching R; Nobis T; Nowgesic E; O'Brien-Teengs D; Whitebird W; Zoccole A; Hull M; Jaworsky D; Rachlis A; Rourke S; Burchell AN; Cooper C; Hogg R; Klein MB; Machouf N; Montaner J; Tsoukas C; Raboud J; ;
    Antivir Ther; 2017; 22(4):325-335. PubMed ID: 27925609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.
    Calkins KL; Lesko CR; Chander G; Moore RD; Lau B
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort.
    Tanner Z; Lachowsky N; Ding E; Samji H; Hull M; Cescon A; Patterson S; Chia J; Leslie A; Raboud J; Loutfy M; Cooper C; Klein M; Machouf N; Tsoukas C; Montaner J; Hogg RS;
    BMC Infect Dis; 2016 Oct; 16(1):590. PubMed ID: 27769246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.
    May MT; Justice AC; Birnie K; Ingle SM; Smit C; Smith C; Neau D; Guiguet M; Schwarze-Zander C; Moreno S; Guest JL; Monforte Ad; Tural C; Gill MJ; Bregenzer A; Kirk O; Saag M; Sterling TR; Crane HM; Sterne JA
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):348-54. PubMed ID: 25848927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
    Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
    Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.
    Small W; Milloy MJ; McNeil R; Maher L; Kerr T
    AIDS Res Ther; 2016; 13():26. PubMed ID: 27462360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.
    Hanna DB; Buchacz K; Gebo KA; Hessol NA; Horberg MA; Jacobson LP; Kirk GD; Kitahata MM; Korthuis PT; Moore RD; Napravnik S; Patel P; Silverberg MJ; Sterling TR; Willig JH; Lau B; Althoff KN; Crane HM; Collier AC; Samji H; Thorne JE; Gill MJ; Klein MB; Martin JN; Rodriguez B; Rourke SB; Gange SJ;
    Clin Infect Dis; 2013 Apr; 56(8):1174-82. PubMed ID: 23315317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare.
    Tapp C; Milloy MJ; Kerr T; Zhang R; Guillemi S; Hogg RS; Montaner J; Wood E
    BMC Infect Dis; 2011 Apr; 11():86. PubMed ID: 21466704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.
    Cescon A; Patterson S; Davey C; Ding E; Raboud JM; Chan K; Loutfy MR; Cooper C; Burchell AN; Palmer AK; Tsoukas C; Machouf N; Klein MB; Rourke SB; Rachlis A; Hogg RS; Montaner JS;
    J Int AIDS Soc; 2015; 18(1):20024. PubMed ID: 26443752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
    Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
    BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.